Hyperbaric Oxygen Therapy of Severe Traumatic Brain Injury in Children and Adolescents
Authors: V. Smolka, E. Klásková, M. Hájek, M. Rohanová, D. Aleksijevič, J. Zapletalová, J. Wiedermann
Authors - sphere of activity: 1Jednotka intenzivní a resuscitační péče, Dětská klinika LF UP a FN Olomouc, 2Centrum hyperbarické medicíny, Městská nemocnice Ostrava
Article: Cesk Slov Neurol N 2012; 75/108(4): 485-489
Category: Short Communication
Number of articles displayed: 117x
Recent studies have suggested that hyperbaric oxygen therapy (HBOT) might be a relatively safe and promising treatment for children patients with severe traumatic brain injury (TBI).
Patients and methods:
From June 2006 to February 2010 we referred seven (age 2–17 years) of the 15 children (11 male) after severe TBI (GCS ≤8) treated at our PICU to HBOT. We analysed Glasgow Coma Scale (GCS) before and after acute treatment, Paediatric Risk of Mortality (PRISM) on admission to PICU, Glasgow Outcome Scale (GOS) and endocrine functions after 6 months from an injury in all admitted patients. The patients received HBOT in a multiplace chamber. Oxygen (100% O2, compression to 2 ATA) was delivered to patients over 80 min every 24 h.
HBOT was indicated in patients who suffered prolonged disturbance of consciousness after an acute treatment of the TBI. The median interval from the injury to receiving HBOT was ± 17.7 days (10–22 days). GCS after an acute treatment and PRISM score on admission of children receiving HBOT were significantly different from children without HBOT (p <0.001 and p = 0.003, respectively). The patients received between 3 and 22 courses of HBOT (mean of ±10.9 sessions per patient). Adverse events were observed in three patients. There was no statistical difference in GOS between HBOT treated and untreated patients after six months from the injury. There were no changes in endocrine function in any of the patients.
HBOT appears to be beneficial as an adjunctive treatment in children and adolescents with disturbed consciousness following an acute treatment of severe TBI with no major adverse events.
traumatic brain injury – hyperbaric oxygen therapy – neuroprotective effect – endocrine function
The full wording of this article is available only to registered users. Plese register and you can read this article immediately.
If you are a subscriber, log in and enter the subscriber code from your magazine cover.
If you are not a subscriber, log in for unlimited access to older editions.
Tento článek si můžete přečíst pokud si aktivujete Premium účet.
SubscriptionSubscribe the Journal
The subscription grants you full access to all the articles.
Issue No.: 2 / 2013
- Use of Botulinum Toxin in Neurology | views: 323
- An Association between Depression and Emotion Recognition from the Facial Expression in Mild Cognitive Impairment | views: 209
- Ultra-Early Evacuation of Intracerebral Spontaneous Hematomas | views: 127
- The Changing Face of Parkinsonian Neurodegeneration | views: 121
- Creutzfeldt-Jacob disease | views: 117
- High-Grade Glioma of the Caudal Part of the Spinal Cord Mimicking Myelitis – a Case Report | views: 103
- National Stroke Register (IKTA) – Is It Needed? | views: 102
- Quality of Life in Patients with Dementia | views: 102
- Evaluation of Cortical Activity Associated with Filling of Urinary Bladder Using Functional Magnetic Resonance Imaging | views: 87
- Atlantooccipital Dislocation – a Series of Six Patients and Topic Review | views: 83